Clinical Trial: Examining the Efficacy of tDCS in the Attenuation of Epileptic Paroxysmal Discharges and Clinical Seizures

Study Status: Completed
Recruit Status: Completed
Study Type: Interventional

Official Title: Examining the Efficacy of tDCS in the Attenuation of Epileptic Paroxysmal Discharges and Clinical Seizures

Brief Summary: The current study examined the feasibility of High-Definition tDCS (HD-tDCS) in reducing epileptiform activity in a 30-month-old child suffering from early onset epileptic encephalopathy. HD-tDCS was administered over 10 intervention days spanning two weeks including pre- and post-intervention video-electroencephalography (EEG) monitoring.

Detailed Summary:
Sponsor: Herzog Hospital

Current Primary Outcome: change in seizure frequency from baseline [ Time Frame: day 1, day 3, day 5, day 6, day 8, day 10, day 13, day 20, day 27, day 33, day 40, day 50 ]

Original Primary Outcome: Same as current

Current Secondary Outcome:

Original Secondary Outcome:

Information By: Herzog Hospital

Dates:
Date Received: November 1, 2016
Date Started: February 2016
Date Completion:
Last Updated: November 7, 2016
Last Verified: November 2016